4//SEC Filing
German Christopher Paul 4
Accession 0001104659-25-027336
CIK 0001649904other
Filed
Mar 23, 8:00 PM ET
Accepted
Mar 24, 5:47 PM ET
Size
9.3 KB
Accession
0001104659-25-027336
Insider Transaction Report
Form 4
German Christopher Paul
Corporate Controller & CAO
Transactions
- Sale
Common Stock
2025-03-21$54.23/sh−344$18,655→ 2,889 total - Exercise/Conversion
Restricted Stock Units
2025-03-20−1,163→ 2,324 total→ Common Stock (1,163 underlying) - Exercise/Conversion
Common Stock
2025-03-20+1,163→ 3,233 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F2]The sale reported in this Form 4 was effected pursuant to non-Rule 10b5-1 trading arrangement, as defined in Item 408(a) of Regulation S-K, solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.
- [F3]The restricted stock units have vested or will vest as to 25% of the total shares on each of March 20, 2024, March 20, 2025, March 20, 2026 and March 20, 2027, subject to the Reporting Person's continued service on each such vesting date. The restricted stock units have no expiration date.
Documents
Issuer
RHYTHM PHARMACEUTICALS, INC.
CIK 0001649904
Entity typeother
Related Parties
1- filerCIK 0001260835
Filing Metadata
- Form type
- 4
- Filed
- Mar 23, 8:00 PM ET
- Accepted
- Mar 24, 5:47 PM ET
- Size
- 9.3 KB